Does Your Condition Qualify?
New Jersey's medical cannabis program covers 18 qualifying conditions. If you have a diagnosis on this list, you may be eligible for medical cannabis certification — covered by your insurance.
All qualifying conditions
Chronic Pain
Persistent pain lasting three months or more, from any cause. The most common reason NJ patients seek medical cannabis certification.
Learn more →Anxiety
Generalized anxiety, panic disorder, social anxiety, and related anxiety conditions that affect your quality of life.
Learn more →PTSD
Post-traumatic stress disorder affecting veterans, first responders, survivors of trauma, and others. Cannabis may help with PTSD sleep problems and nightmares.
Learn more →Cancer
For patients managing cancer symptoms and treatment side effects including nausea, pain, loss of appetite, and sleep disruption. Fast-tracked certification available for terminal diagnoses.
Learn more →Migraine
Chronic or episodic migraines. Cannabis may help both prevent attacks and ease them once they start.
Learn more →Epilepsy / Seizure Disorder
Epilepsy and other seizure disorders, particularly treatment-resistant forms. A purified CBD medicine (Epidiolex) is FDA-approved for specific seizure types.
Learn more →Multiple Sclerosis
MS-related spasticity, pain, sleep disturbance, and fatigue. Cannabis is one of the most studied and supported therapeutic options for MS symptom management.
Learn more →ALS
Amyotrophic lateral sclerosis (Lou Gehrig's disease). Cannabis therapy can help manage ALS symptoms including muscle cramping, spasticity, pain, and appetite loss. Expedited certification available.
Learn more →IBD / Crohn's Disease
Inflammatory bowel disease including Crohn's disease and ulcerative colitis. Cannabis may help with pain, appetite and other symptoms.
Learn more →Glaucoma
Glaucoma with elevated intraocular pressure. Cannabis lowers eye pressure for a few hours at a time; it is not a replacement for standard treatment.
Learn more →HIV / AIDS
For patients managing HIV/AIDS-related wasting syndrome, neuropathic pain, nausea from antiretroviral therapy, and fatigue. A long-standing qualifying condition with clinical evidence behind it.
Learn more →Muscular Dystrophy
Muscular dystrophy and related neuromuscular diseases. Cannabis may help manage spasticity, pain, sleep disruption, and the psychological burden of progressive muscle disease.
Learn more →Tourette Syndrome
Tourette syndrome and the tics that come with it. Small studies suggest cannabis may reduce tic frequency and severity.
Learn more →Opioid Use Disorder
Cannabis as part of a harm-reduction strategy for opioid use disorder and opioid tapering. For some patients it can support recovery alongside standard treatment.
Learn more →Terminal Illness
Patients with terminal illness and a life expectancy of one year or less. We prioritize these patients for expedited evaluation and work with palliative care teams to ensure seamless coordination.
Learn more →Dysmenorrhea
Severe menstrual pain and cramping (dysmenorrhea) that interferes with daily life.
Learn more →Sickle Cell Anemia New 2026
Added to the NJMMP in January 2026. Cannabis therapy may help manage the severe pain crises, chronic pain, and inflammation associated with sickle cell disease.
Learn more →Intractable Skeletal Muscular Spasticity
Severe spasticity of skeletal muscles that has not responded to standard antispasticity therapies, often associated with spinal cord injury, TBI, stroke, or cerebral palsy.
Learn more →Don't see your condition?
The 18 conditions above are the current qualifying conditions under the NJ Medicinal Cannabis Program. If you have a condition not on this list, you may still be a candidate for other treatments at PremierMD.
Patients with depression, other mood disorders, or treatment-resistant conditions may benefit from our sister practices: QuietMind Health (psychiatric medication management) or Spravato NJ (esketamine treatment for treatment-resistant depression).
See our FAQ